These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1825127)

  • 1. Cardiac content of brain natriuretic peptide in DOCA salt-hypertensive rats.
    Yokota N; Aburaya M; Yamamoto Y; Kato J; Kitamura K; Kida O; Eto T; Minamino N; Kangawa K; Matsuo H
    Life Sci; 1991; 48(5):397-402. PubMed ID: 1825127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased release of atrial natriuretic polypeptides in rats with DOCA-salt hypertension.
    Sugimoto T; Ishii M; Hirata Y; Matsuoka H; Sugimoto T; Miyata A; Toshimori T; Masuda H; Kangawa K; Matsuo H
    Life Sci; 1986 Apr; 38(15):1351-8. PubMed ID: 2937987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution and molecular forms of brain natriuretic peptide in the central nervous system, heart and peripheral tissue of rat.
    Aburaya M; Minamino N; Hino J; Kangawa K; Matsuo H
    Biochem Biophys Res Commun; 1989 Dec; 165(2):880-7. PubMed ID: 2532011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased plasma brain natriuretic peptide levels in DOCA-salt hypertensive rats: relation to blood pressure and cardiac concentration.
    Yokota N; Aburaya M; Yamamoto Y; Kato J; Kitamura K; Kida O; Eto T; Minamino N; Kangawa K; Matsuo H
    Biochem Biophys Res Commun; 1990 Dec; 173(2):632-8. PubMed ID: 2148083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phasic plasma atrial natriuretic polypeptide changes in DOCA-salt hypertensive rats.
    Sato Y; Ito Y; Ando K; Ogata E; Fujita T
    Jpn Heart J; 1990 Sep; 31(5):703-11. PubMed ID: 2148777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiological role of augmented atrial natriuretic polypeptide gene expression in DOCA-salt hypertension. Effects of atrial natriuretic polypeptide monoclonal antibody.
    Itoh H; Nakao K; Mukoyama M; Arai H; Yamada T; Saito Y; Shiono S; Hosoda K; Shirakami G; Suga S
    Am J Hypertens; 1991 Jan; 4(1 Pt 1):39-44. PubMed ID: 1706603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood pressure and renal responses to synthetic rat atrial natriuretic factor in deoxycorticosterone acetate-salt hypertension.
    Kohzuki M; Abe K; Yasujima M; Kasai Y; Hiwatari M; Kanazawa M; Sato M; Omata K; Kudo K; Takeuchi K
    Tohoku J Exp Med; 1989 Apr; 157(4):301-11. PubMed ID: 2525826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissociation of cardiac hypertrophy, myosin heavy chain isoform expression, and natriuretic peptide production in DOCA-salt rats.
    Yokota N; Bruneau BG; Fernandez BE; de Bold ML; Piazza LA; Eid H; de Bold AJ
    Am J Hypertens; 1995 Mar; 8(3):301-10. PubMed ID: 7540847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial natriuretic factor content of brain nuclei in deoxycorticosterone acetate-salt hypertension in the rat.
    Geiger H; Bahner U; Palkovits M; Hupe J; Heidland A
    Clin Sci (Lond); 1989 Nov; 77(5):529-34. PubMed ID: 2531054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The changes in natriuretic peptide receptors (NP-R) in the lung and kidney in DOCA-salt hypertensive rats].
    Liu LM; Yoshimi T
    Nihon Naibunpi Gakkai Zasshi; 1995 May; 71(4):587-96. PubMed ID: 7796923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of endogenous atrial natriuretic peptide in DOCA-salt hypertensive rats. Effects of a novel nonpeptide antagonist for atrial natriuretic peptide receptor.
    Hirata Y; Matsuoka H; Suzuki E; Hayakawa H; Sugimoto T; Matsuda Y; Morishita Y; Kangawa K; Minamino N; Matsuo H
    Circulation; 1993 Feb; 87(2):554-61. PubMed ID: 8381060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased density of vascular receptors for atrial natriuretic peptide in DOCA-salt hypertensive rats.
    Schiffrin EL; St-Louis J
    Hypertension; 1987 May; 9(5):504-12. PubMed ID: 3032791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial natriuretic peptide receptors in renal papilla of DOCA-salt hypertensive rats.
    Nuglozeh E; Gauquelin G; Garcia R; Tremblay J; Schiffrin EL
    Am J Physiol; 1990 Jul; 259(1 Pt 2):F130-7. PubMed ID: 2165357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic blockade of endogenous atrial natriuretic polypeptide (ANP) by monoclonal antibody against ANP accelerates the development of hypertension in spontaneously hypertensive and deoxycorticosterone acetate-salt-hypertensive rats.
    Itoh H; Nakao K; Mukoyama M; Yamada T; Hosoda K; Shirakami G; Morii N; Sugawara A; Saito Y; Shiono S
    J Clin Invest; 1989 Jul; 84(1):145-54. PubMed ID: 2544622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased renal atrial natriuretic peptide synthesis in rats with deoxycorticosterone acetate-salt treatment.
    Lee YJ; Shin SJ; Tan MS; Hsieh TJ; Tsai JH
    Am J Physiol; 1996 Oct; 271(4 Pt 2):F779-89. PubMed ID: 8898007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue-specific regulation of renal and cardiac atrial natriuretic factor gene expression in deoxycorticosterone acetate-salt rats.
    Ogawa T; Bruneau BG; Yokota N; de Bold ML; de Bold AJ
    Hypertension; 1997 Dec; 30(6):1342-7. PubMed ID: 9403551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of selective ET(A) receptor blockade on natriuretic peptide gene expression in DOCA-salt hypertension.
    Bianciotti LG; De Bold AJ
    Am J Physiol Heart Circ Physiol; 2000 Jul; 279(1):H93-H101. PubMed ID: 10899045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of brain angiotensin II and C-type natriuretic peptide in deoxycorticosterone acetate-salt hypertension in rats.
    Nishimura M; Ohtsuka K; Sakamoto M; Nanbu A; Takahashi H; Yoshimura M
    J Hypertens; 1998 Aug; 16(8):1175-85. PubMed ID: 9794722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in blood pressure and extracellular fluid with taurine in DOCA-salt rats.
    Fujita T; Sato Y
    Am J Physiol; 1986 Jun; 250(6 Pt 2):R1014-20. PubMed ID: 3717374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blunted pressor responsiveness to quinpirole, a specific dopamine D2 receptor agonist, in conscious deoxycorticosterone acetate/NaCl hypertensive rats is related to atrial natriuretic peptide release.
    Chen YF; Jin HK; Paul R; Nagahama S
    J Pharmacol Exp Ther; 1988 Aug; 246(2):485-92. PubMed ID: 2969976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.